Casim, Halima .
HRN: 11-74-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2024
CEFUROXIME 500MG (TAB)
06/01/2024
06/08/2024
PO
500mg
BID X 7 Days
UTI; Pus Cells: 15-20; Rbc: 10-15
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes